Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
JPMorgan Chase said it passed the latest supervisory stress test and is adjusting its payout outlook, pointing to a strong capital position.
THE APEX TIMES
THE APEX TIMES
BlackRock reported second-quarter earnings and revenue that topped analyst expectations, supported by a year-over-year jump in assets under management and net inflows, while investors also focused on expense pressures.
THE APEX TIMES
The company’s settlement resolves a U.S. Federal Trade Commission case over access to repair information, a move Deere says could help sustain investment in service options while keeping equipment on the road.
THE APEX TIMES
A new market note points to an average brokerage recommendation for UnitedHealth, but questions remain about whether analyst “buy” outlines reliably translate into future performance.
THE APEX TIMES
A market update highlighted how BlackRock’s second-quarter performance for the quarter ended June 2026 stacked up against analyst expectations, spotlighting several metrics that typically drive interpretation of asset manager earnings.
THE APEX TIMES
A Yahoo Finance roundup of Morgan Stanley’s second-quarter performance focuses on the metrics investors typically watch most and notes that some figures may be best understood in comparison with Wall Street estimates.
THE APEX TIMES
A Yahoo Finance market note pointed to an optimistic average brokerage recommendation for CVS Health, even as it raised questions about whether the stock’s recent appeal reflects underlying performance.
THE APEX TIMES
A market recap published by Yahoo Finance on Tuesday pointed readers toward a comparison of Johnson & Johnson’s key operating indicators versus consensus estimates, arguing the headline profit and revenue figures alone may not tell the full story.
THE APEX TIMES
The move follows a market report linking the battery maker to Amazon’s internal logistics equipment, a development investors appeared to treat as potentially meaningful commercial validation.
